His Excellency Majid Al Fayyadh is the Chief Executive Officer of King Faisal Specialist Hospital and Research Centre (KFSHRC) in Saudi Arabia, a leading tertiary and quaternary academic medical institution in the region. Since his appointment in 2017, he has led a wide-ranging transformation of the organization, strengthening clinical and medical excellence, research output, education, quality and patient safety, and long-term financial sustainability. Under his leadership, KFSHRC transitioned to an independent, non-profit model and has consistently ranked as the top hospital in the Middle East and Africa and among the world’s leading healthcare institutions. During this period, the hospital expanded specialized services across its campuses, advanced precision and genomic medicine, pioneered in-house CAR-T cell manufacturing, and accelerated innovation aligned with Saudi Arabia’s National Transformation Program and Vision 2030.
Dr. Al Fayyadh is a pediatric cardiologist and electrophysiologist by training, he served as an advisor to the Director of the Vision Realization Office at the Saudi Ministry of Health, contributing to national healthcare reform initiatives. Earlier in his career, he received competitive research grants from the Dubai Harvard Foundation for Medical Research and the King Abdulaziz City for Science and Technology. His combined clinical, academic, and executive background has shaped a leadership approach focused on institutional excellence, innovation, and global impact in advanced healthcare delivery.
The 100 CEOs featured here reflect the diversity and complexity of modern oncology leadership. In 2025, some lead the world’s largest cancer institutions; others guide specialized societies or emerging innovators. What unites them is responsibility: for millions of patients, for the integrity of science, and for the future direction of cancer care globally.
This list is not a celebration of power, but a recognition of stewardship, accountability, and impact – and of the leaders whose choices continue to shape the fight against cancer. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential CEOs in Oncology in 2025 and stay tuned for other special category nominations.
